Early in the drug development process, clients face the daunting task of identifying indications with enough commercial potential to pursue in R&D.

Equinox Group, using screening criteria honed through years of application and refinement, helps clients sift through the many possibilities to discover the most promising new disease areas in which to seek opportunities. We can also identify specific assets that might be available for licensing and assess their attractiveness.